SCHEDULE 13G/A: PRIMECAP Management Co. Updates Passive Stake in LivaNova PLC to 8.76%

PRIMECAP Management Co. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 8.76% in LivaNova PLC as of December 31, 2024.

Summary

• PRIMECAP Management Co. reported beneficial ownership of 4,754,060 common shares of LivaNova PLC.
• This stake represents 8.76% of LivaNova PLC's outstanding common shares.
• The filing is an Amendment No. 7 to a previously filed Schedule 13G, indicating an update to PRIMECAP's passive investment position.
• PRIMECAP Management Co. holds sole voting power over 4,517,200 shares and sole dispositive power over all 4,754,060 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of LivaNova PLC.

Sentiment

Score: 6

Explanation: The filing indicates a significant, passive stake by a reputable investment adviser, suggesting continued institutional interest in LivaNova PLC, which is generally viewed as a positive signal of investor confidence.

Positives

• PRIMECAP Management Co., a prominent investment adviser, maintains a significant passive stake of 8.76% in LivaNova PLC, signaling continued institutional confidence in the company.
• The filing explicitly states that the shares are held in the ordinary course of business and not for the purpose of influencing control, which suggests a long-term, passive investment strategy.

Future Outlook

This Schedule 13G filing does not contain forward-looking statements or guidance regarding LivaNova PLC's future performance or outlook, as it is solely a disclosure of beneficial ownership by an investment adviser.

Industry Context

This filing indicates that a major institutional investment adviser, PRIMECAP Management Co., continues to hold a substantial passive stake in LivaNova PLC, a company operating in the medical technology sector. Such a significant holding by a reputable firm can be viewed as a vote of confidence in the long-term prospects of the company within the broader healthcare industry.

Stakeholder Impact

• Shareholders: The disclosure of a significant passive stake by a major institutional investor may influence market perception and investor confidence in LivaNova PLC's stock.

Key Dates

Keywords

LivaNova PLC, PRIMECAP Management Co., Schedule 13G, beneficial ownership, institutional investor, passive investment, medical technology, healthcare, common stock